BayerAG

News

Reuters - 20 hours ago

BASF hopes pricing power will boost profit growth later in the year

UPDATE 3-BASF hopes pricing power will boost profit growth later in the year Adds CEO comment in paragraphs 2-4, shares in paragraph 6 By Ludwig Burger FRANKFURT, July 26 (Reuters) - BASF BASFn.DE is banking on regaining pricing power to speed up earnings growth in the second half after the German chemicals group's adjusted profit edged 0.6% higher in the second quarter, with China playing a key role.

Reuters - 1 day ago

Bayer's Monsanto to pay $160 mln to resolve Seattle's PCB contamination lawsuit

Bayer's Monsanto to pay $160 mln to resolve Seattle's PCB contamination lawsuit By Jonathan Stempel July 25 (Reuters) - Monsanto will pay $160 million to settle a lawsuit by the city of Seattle that accused the unit of Germany's Bayer BAYGn.DE of polluting the city's drainage system and the local Lower Duwamish River with toxic chemicals known as PCBs.

Reuters - 2 days ago

Australian judge dismisses lawsuit claiming Bayer weedkiller causes blood cancer

UPDATE 2-Australian judge dismisses lawsuit claiming Bayer weedkiller causes blood cancer Recasts and writes through with comments from judge, Bayer and plaintiffs' lawyers By Peter Hobson and Alasdair Pal CANBERRA, July 25 (Reuters) - An Australian judge on Thursday dismissed a class action lawsuit claiming Bayer's BAYGn.DE Roundup weedkiller can cause a type of blood cancer, a ruling the company said it would seek to leverage in similar cases being fought in the United States.

Reuters - 2 days ago

Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancer

Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancer SYDNEY, July 25 (Reuters) - An Australian judge said on Thursday it was not proven that an ingredient in Bayer's BAYGn.DE Roundup weedkiller increases the risk of cancer in users. Reporting by Alasdair Pal in Sydney Editing by Praveen Menon

Reuters - 2 days ago

Roche lifts 2024 profit guidance on strong drug sales

UPDATE 2-Roche lifts 2024 profit guidance on strong drug sales First-half operating profit growth beats analyst estimates Revenue from eye drug Vabysmo nearly doubles, beats estimates Expects close to 10% adjusted profit growth, up vs previous Shares traded near 1-year high earlier on Thursday Adds details on eye drug in paragraphs 5 and 7, details on CEO's strategy in last two paragraphs By Ludwig Burger FRANKFURT, July 25 (Reuters) - Roche ROG.S on Thursday raised its full-year earnings foreca

Reuters - 2 days ago

Australian court to rule on whether Bayer weedkiller can cause blood cancer

Australian court to rule on whether Bayer weedkiller can cause blood cancer By Peter Hobson and Alasdair Pal CANBERRA, July 25 (Reuters) - An Australian judge will rule on Thursday on whether Bayer's BAYGn.DE Roundup weedkiller can cause a type of blood cancer, a closely watched decision that follows some jury verdicts in similar U.S. cases that have found for the plaintiffs.

Reuters - 4 days ago

Bayer heads to trial in US antitrust lawsuit over flea, tick medication

Bayer heads to trial in US antitrust lawsuit over flea, tick medication By Mike Scarcella July 22 (Reuters) - A former unit of German life-sciences giant Bayer BAYGn.DE is squaring off in California federal court this week with a petcare startup that claims the company tried to block competition for animal tick and flea treatments. Jurors in San Jose federal court heard opening statements on Monday in the antitrust case, which was brought by Tevra Brands in 2019 against Bayer Healthcare.

Reuters - 1 week ago

Let the chips fall where they may

LIVE MARKETS-Let the chips fall where they may Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com LET THE CHIPS FALL WHERE THEY MAY European equities are heading for a downbeat start today, with the exception of London's FTSE 100 .FTSE , which may get a little boost from British data that showed inflation held at 2% last month.

Reuters - 1 week ago

Bayer eyes wider Nubeqa use on new prostate cancer trial data

UPDATE 1-Bayer eyes wider Nubeqa use on new prostate cancer trial data Rewrites throughout By Ludwig Burger FRANKFURT, July 17 (Reuters) - Bayer BAYGn.DE said on Wednesday its Nubeqa drug was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, underpinning growth prospects for one of the German drugmaker's key pharmaceutical products.

Reuters - 1 week ago

Bayer says darolutamide shown to slow prostate cancer progression

Bayer says darolutamide shown to slow prostate cancer progression FRANKFURT, July 17 (Reuters) - Bayer BAYGn.DE said on Wednesday its drug candidate darolutamide was shown to slow the progression of certain types of prostate cancer in a late-stage trial. Bayer is working on darolutamide jointly with Filand's Orion ORNBV.HE . Reporting by Ludwig Bur

Reuters - 1 week ago

Orion Says Phase III Aranote Trial Of Darolutamide Meets Primary Endpoint

BRIEF-Orion Says Phase III Aranote Trial Of Darolutamide Meets Primary Endpoint July 17 (Reuters) - Orion Oyj ORNBV.HE : REG-INSIDE INFORMATION: PHASE III ARANOTE TRIAL OF DAROLUTAMIDE IN COMBINATION WITH ANDROGEN DEPRIVATION THERAPY IN MEN WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER MEETS PRIMARY ENDPOINT ORION AND BAYER'S PHASE III ARANOTE

Reuters - 2 weeks ago

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Unilever July 15 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts and 36 branch closures, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * METSO METSO.HE : The Finnis

Reuters - 2 weeks ago

Bayer: Askbio Receives FDA Fast Track Designation For 1005 Parkinson's Therapy

BRIEF-Bayer: Askbio Receives FDA Fast Track Designation For AB-1005 Parkinson's Therapy July 11 (Reuters) - Bayer AG BAYGn.DE : ASKBIO RECEIVES FDA FAST TRACK AND MHRA INNOVATION PASSPORT DESIGNATIONS FOR AB-1005 INVESTIGATIONAL GDNF GENE THERAPY FOR PARKINSON'S DISEASE ASKBIO IS CURRENTLY ENROLLING PATIENTS IN ITS PHASE II REGENERATE-PD TRIAL IN U

Reuters - 2 weeks ago

BASF to cease production of glufosinate-ammonium weed killer

UPDATE 2-BASF to cease production of glufosinate-ammonium weed killer Recasts first paragraph to add that BASF said it will cease production of the weed killer BERLIN, July 10 (Reuters) - BASF BASFn.DE plans to shut down production of the glufosinate-ammonium weed killer due to growing competition as well as high energy and raw materials costs, the German chemicals group said on Wednesday.

Reuters - 2 weeks ago

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds details on fresh job cuts July 9 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts and 36 branch closures, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * METSO METSO

Reuters - 4 weeks ago

Bayer And Rad AI Announce Collaboration Agreement

BRIEF-Bayer And Rad AI Announce Collaboration Agreement June 27 (Reuters) - BAYER AG BAYGn.DE : BAYER AND RAD AI ANNOUNCE COLLABORATION AGREEMENT BAYER AND RAD AI ARE ANNOUNCING A COLLABORATION TO BRING RAD AI'S CUTTING EDGE AI RADIOLOGY OPERATIONAL SOLUTIONS TO CALANTIC ™ DIGITAL SOLUTION CUSTOMERS Source text for Eikon: ID:nBw8vRJLZa Further co

Reuters - 4 weeks ago

German chemical sector employers, union agree 6.85% pay hike over 20 months

UPDATE 1-German chemical sector employers, union agree 6.85% pay hike over 20 months Adds companies, background on metalworking sector FRANKFURT, June 27 (Reuters) - Germany's BAVC chemical industry association on Thursday agreed with union IGBCE on staggered wage hikes that will give workers 6.85% higher pay over 20 months. As part of the deal, the 585,000 workers covered by the agreement will receive an additional day off per year , the union and the employers' association said in separate sta

Reuters - 4 weeks ago

Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia

Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia By Michael Erman NEW YORK, June 26 (Reuters) - A top Bayer BAYGn.DE pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as part of the company's internal reorganization.

Reuters - 1 month ago

Bayer: AskBio Starts Recruitment To Its Phase 2 Parkinson's Disease Trial

BRIEF-Bayer: AskBio Starts Recruitment To Its Phase 2 Parkinson's Disease Trial June 25 (Reuters) - BAYER AG BAYGn.DE : ASKBIO INITIATES RECRUITMENT TO ITS PHASE 2 PARKINSON'S DISEASE TRIAL Further company coverage: [BAYGn.DE] (Gdansk Newsroom)

Reuters - 1 month ago

Bayer looks to AI to combat herbicide resistance faster

Bayer looks to AI to combat herbicide resistance faster By Renee Hickman CHICAGO, June 18 (Reuters) - Bayer's crop science division is increasingly turning to artificial intelligence in its battle against crop killing weeds, the company told Reuters. Weeds are growing resistant to the herbicides already on the market, and agribusiness companies like Bayer are in a desperate search for new modes of action to help farmers kill them.

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

BayerAG

News

Conditions

Popular Assets

XM Live Chat